The majority of synthetic drugs are not im munogenic unless they co-valently bind to a macromolecule, usually a protein. Formation of co-valent linkages can be forged if the drug has functional groups capable of reacting with nucleo philes or if such groups are generated by means of metabolic conversion. The subject of this paper explores a novel way by which co-valent bonds may be formed and illustrates the significance for immunotoxic drug reactions. To answer this question a model compound, chlorhexidine, was studied. Ohtoshi et al. (1986) reported that a formulation containing chlorhexi dine was capable of eliciting clinical anaphylaxis.
They were able to demonstrate IgE antibodies with specificity to chlorhexidine in the serum of pa tients who had experienced an anaphylactic reaction.
Chlorhexidine is a bis-biguanide which is inert to nucleophilic attack.
Yet to induce specific antibodies there must be a mechanism for co-valent binding to protein.
Kinetic studies which monitored the formation of N-Cl showed that conversion was extremely rapid and could be achieved with chlorine levels down to 1 ppm (Rose, personal communication). Subsequently a number of different protein car riers were substituted and the ability of the various conjugates to induce an antibody response were measured.
Result of the Study : Table 1 shows the effect of varying the concentrat ion of chlorine on the immunogenicity of chlorhexidine-keyhole limpet haemocyanin (KLH) conjugates. Allergy, 16 : 155-162 (1986) .
